| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/08/2001 | WO2000056737A3 Calanolides for inhibiting btk |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378302A1 Thienopyranecarboxamide derivatives |
| 02/08/2001 | CA2376927A1 Oxazinocarbazoles for the treatment of cns diseases |
| 02/07/2001 | EP1074260A1 IL-12 Production inhibitor |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073723A2 Ste20-related protein kinases |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 02/07/2001 | EP1073650A1 Guanidine derivatives |
| 02/07/2001 | EP1073641A2 New substituted amides, their production and their use |
| 02/07/2001 | EP1073638A1 Heterocyclically substituted amides, their production and their use |
| 02/07/2001 | EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors |
| 02/07/2001 | EP1073631A1 New substituted amides, their production and their use |
| 02/07/2001 | CN1283201A K receptor opioid peptides |
| 02/07/2001 | CN1282740A Intermediate compound for preparing xibo ketone |
| 02/07/2001 | CN1282591A Shenkang pill-for treating nephitis |
| 02/07/2001 | CN1282588A Medicine for curing hepatism and nephrosis |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives |
| 02/06/2001 | CA2155872C Oxytocin antagonist |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 02/01/2001 | WO2001007417A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007057A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000059493A3 Improved dialysis solutions and methods |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378395A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 01/31/2001 | EP1072597A1 Pyrazoles and their use as endothelin antagonists |
| 01/31/2001 | EP1072260A1 Transdermal systems for the release of muscarinic receptor antagonists and use thereof for treatement of smooth muscle spasms in urology |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071423A1 Antagonists of gonadotropin releasing hormone |
| 01/31/2001 | CN1282321A Potassium channel openers |
| 01/31/2001 | CN1061235C Pharmaceutical composition for prophlaxis and treatment of premature ejaculation caused by neuroticism |
| 01/30/2001 | US6180665 Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180619 Prenyl transferase inhibitors |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180355 Method for diagnosing and treating chronic pelvic pain syndrome |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005978A1 FimH ADHESIN-BASED VACCINES |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005827A1 Fima PILUS-BASED VACCINES |
| 01/25/2001 | WO2001005805A2 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/25/2001 | WO2001005795A1 Remedies or preventives for frequent urination or urinary incontinence |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005765A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 01/25/2001 | WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | WO2001005435A2 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | WO2001005398A1 Phosphate transport inhibitors |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005383A2 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 01/25/2001 | WO2001005380A1 Sustained release compositions, process for producing the same and use thereof |
| 01/25/2001 | WO2000064892A3 Thiazolidinedione derivative and its use as antidiabetic |
| 01/25/2001 | WO2000061174A3 Use of pegylated interferon alpha for renal cell carcinoma treatment |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000059946A8 Hydroxymatairesinol in cancer prevention |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000054815A3 Expression of dna or proteins in c. elegans |
| 01/25/2001 | WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 01/25/2001 | DE19934523A1 Transdermalsysteme zur Abgabe von Muscarin-Rezeptor-Antagonisten und ihre Verwendung zur Behandlung von Spasmen der glatten Muskulatur im urologischen Bereich Transdermal systems for the delivery of muscarinic receptor antagonists and their use for treating spasm of smooth muscle in the urological field |
| 01/25/2001 | DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives |
| 01/25/2001 | DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379968A1 Gtp-binding protein associated factors |
| 01/25/2001 | CA2379657A1 Phosphate transport inhibitors |
| 01/25/2001 | CA2379577A1 Remedies or preventives for frequent urination or urinary incontinence |
| 01/25/2001 | CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |